Stay updated on Nivolumab/Ipilimumab vs Chemo/Nivolumab in SqLC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab/Ipilimumab vs Chemo/Nivolumab in SqLC Clinical Trial page.

Latest updates to the Nivolumab/Ipilimumab vs Chemo/Nivolumab in SqLC Clinical Trial page
- Check3 days agoChange DetectedThe page now includes a consolidated 'Locations' section with new entries for Forlì-Cesena, Italia, Potenza, and Verona, and a revision tag (v3.3.3); the previous location listings were removed.SummaryDifference0.4%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedUpdated the Publications description to indicate PubMed publications are automatically filled from a public database, and added Revision: v3.3.2; updated the deletions note to remove the older PubMed description and Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check39 days agoChange DetectedRemoved a site-wide government funding/operating status notice from the page; the study details and content remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check53 days agoChange DetectedNo significant content changes were observed on the study page; the structure and key information about NCT03823625 remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check82 days agoChange DetectedSummary of changes: updated operating-status notice and a version bump to v3.2.0, replacing the previous v3.1.0.SummaryDifference3%

- Check89 days agoChange DetectedUpgrade core software to v3.1.0 and expand contact details with numerous emails and phone numbers; no other substantial content changes detected.SummaryDifference0.1%

Stay in the know with updates to Nivolumab/Ipilimumab vs Chemo/Nivolumab in SqLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab/Ipilimumab vs Chemo/Nivolumab in SqLC Clinical Trial page.